关注
Ryan Sullivan
Ryan Sullivan
Massachusetts General Hospital
在 mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
I Tirosh, B Izar, SM Prakadan, MH Wadsworth, D Treacy, JJ Trombetta, ...
Science 352 (6282), 189-196, 2016
39332016
Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis
DY Wang, JE Salem, JV Cohen, S Chandra, C Menzer, F Ye, S Zhao, ...
JAMA oncology 4 (12), 1721-1728, 2018
20222018
Defining T cell states associated with response to checkpoint immunotherapy in melanoma
M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ...
Cell 175 (4), 998-1013. e20, 2018
14112018
Myocarditis in patients treated with immune checkpoint inhibitors
SS Mahmood, MG Fradley, JV Cohen, A Nohria, KL Reynolds, ...
Journal of the American College of Cardiology 71 (16), 1755-1764, 2018
12422018
EGFR mutations and ALK rearrangements are associated with low response rates to PD-1 pathway blockade in non–small cell lung cancer: a retrospective analysis
JF Gainor, AT Shaw, LV Sequist, X Fu, CG Azzoli, Z Piotrowska, ...
Clinical cancer research 22 (18), 4585-4593, 2016
11222016
A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ...
Cell 175 (4), 984-997. e24, 2018
10462018
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma
DT Frederick, A Piris, AP Cogdill, ZA Cooper, C Lezcano, CR Ferrone, ...
Clinical cancer research 19 (5), 1225-1231, 2013
9962013
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ...
Nature communications 8 (1), 1136, 2017
8232017
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
AM Menzies, DB Johnson, S Ramanujam, VG Atkinson, ANM Wong, ...
Annals of Oncology 28 (2), 368-376, 2017
8092017
Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders
DB Johnson, RJ Sullivan, PA Ott, MS Carlino, NI Khushalani, F Ye, ...
JAMA oncology 2 (2), 234-240, 2016
6282016
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
N Auslander, G Zhang, JS Lee, DT Frederick, B Miao, T Moll, T Tian, ...
Nature medicine 24 (10), 1545-1549, 2018
5872018
Overall survival benefit with tebentafusp in metastatic uveal melanoma
P Nathan, JC Hassel, P Rutkowski, JF Baurain, MO Butler, M Schlaak, ...
New England Journal of Medicine 385 (13), 1196-1206, 2021
5492021
MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
N Wagle, EM Van Allen, DJ Treacy, DT Frederick, ZA Cooper, ...
Cancer discovery 4 (1), 61-68, 2014
5292014
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ...
Nature communications 7 (1), 10582, 2016
5282016
Clusters of circulating tumor cells traverse capillary-sized vessels
SH Au, BD Storey, JC Moore, Q Tang, YL Chen, S Javaid, AF Sarioglu, ...
Proceedings of the National Academy of Sciences 113 (18), 4947-4952, 2016
4742016
Targeted next generation sequencing identifies markers of response to PD-1 blockade
DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ...
Cancer immunology research 4 (11), 959-967, 2016
4722016
Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma
AT Faje, R Sullivan, D Lawrence, NA Tritos, R Fadden, A Klibanski, ...
The Journal of Clinical Endocrinology & Metabolism 99 (11), 4078-4085, 2014
4642014
Resistance to BRAF-targeted therapy in melanoma
RJ Sullivan, KT Flaherty
European journal of cancer 49 (6), 1297-1304, 2013
4242013
High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma
AT Faje, D Lawrence, K Flaherty, C Freedman, R Fadden, K Rubin, ...
Cancer 124 (18), 3706-3714, 2018
4032018
The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution
O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ...
Cell 181 (2), 236-249, 2020
3932020
系统目前无法执行此操作,请稍后再试。
文章 1–20